Rapid risk assessment: Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019
Between 1st February and 26th November 2019, 199 cases of Klebsiella pneumoniae carbapenemase (KPC)-producing carbapenem-resistant Enterobacterales (KPC-CRE) have been detected in Lithuania.
European surveillance of Clostridioides (Clostridium) difficile infections - surveillance protocol version 2.4
ECDC publishes a protocol developed for the surveillance of Clostridioides (Clostridium) difficile infections (CDI) to address the lack of standardised surveillance of CDI in EU Member States.
Outbreak of carbapenemase-producing (NDM-1 and OXA-48) and colistin-resistant Klebsiella pneumoniae ST307, north-east Germany, 2019
Germany has reported an outbreak of carbapenemase-producing (NDM-1 and OXA-48) and colistin-resistant Klebsiella pneumoniae sequence type (ST) 307. As of 21 October 2019, 17 patients in three hospitals and one rehabilitation clinic in Mecklenburg-West Pomerania in north-east Germany have been affected. Six of the 17 cases presented with clinical symptoms of infection, while 11 were identified as be carriers.
Surveillance systems overview for 2018
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2018.
- Chikungunya virus disease
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- Hantavirus infection
- Healthcare-associated infections
- Hepatitis A
- Hepatitis B
- Hepatitis C
- HIV infection
- Invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- Meningococcal disease
- Pneumococcal disease
- Q fever
- Rift Valley fever
- Severe acute respiratory syndrome (SARS)
- Verotoxigenic Escherichia coli infection
- West Nile virus infection
Communicable disease threats report, 6-12 October 2019, week 41
This issue covers the period 6-12 October 2019 and includes updates on Ebola virus disease, extensively drug-resistant Klebsiella pneumoniae, West Nile virus, mass gathering monitoring (Japan, Rugby World Cup 2019), Poliomyelitis, Measles, Zika virus disease, seasonal influenza, XDR-Typhoid fever.
Healthcare-associated infections: surgical site infections - Annual Epidemiological Report for 2017
In 2017, 10 149 SSIs were reported from a total of 648 512 surgical procedures.
Healthcare-associated infections in intensive care units - Annual Epidemiological Report for 2017
In 2017, 8.3% (11 787) of the patients who stayed in intensive-care units (ICUs) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection, or urinary tract infection).
Carbapenem resistant Enterobacteriaceae - second update
Carbapenem resistance in Enterobacteriaceae such as Klebsiella pneumoniae and Escherichia coli poses a significant threat to patients and healthcare systems in all European Union/European Economic Area (EU/EEA) countries. Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high mortality, primarily due to delays in administration of effective treatment and the limited availability of treatment options. Hypervirulent carbapenem-resistant K. pneumoniae strains have been reported presenting an additional threat with a potential for global dissemination. The spread of high risk clones and plasmids carrying carbapenemases in healthcare settings is a major cause of the spread of CRE in EU/EEA countries. Recent events of cross-border importation after patient transfer and large regional outbreaks as well as the worsening epidemiologic situation of carbapenemase-producing CRE in the EU/EEA highlight the high risk for further spread of CRE and the need for enhanced control efforts. Options for control are outlined in the respective section below.
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
Jarlier, V., Diaz Högberg, L., Heuer, O.E., Campos, J., Eckmanns, T., Giske, C.G., Grundmann, H., Johnson, A.P., Kahlmeter, G., Monen, J., Pantosti, A., Rossolini, G.M., van de Sande-Bruinsma, N., Vatopoulos, A., Żabicka, D., Žemličková, H., Monnet, D.L., Simonsen, G.S., Ears-Net Participants
Privacy Statement - Processing of personal data for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
Data are processed for the conduct of the carbapenem- and/or colistin-resistant Enterobacteriaceae (CCRE) survey as part of molecular surveillance of antimicrobial resistant pathogens according to a protocol. For the CCRE survey bacterial isolates (carbapenem and/or colistin-resistant Enterobacteriaceae and susceptible control isolates) and related patient data are collected in hospitals in 37 countries with the aim to determine transmission pathways and improve control measures.